RESEARCH TRIANGLE PARK, NC (October 15, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Tony DiTonno, CEO and Executive Chairman, will provide a status update on the company’s two lead drug development programs on Wednesday, Oct 16, as part of the BIO Investor Forum in San…
RESEARCH TRIANGLE PARK, NC (RTP) – October 18, 2017 – Dignify Therapeutics, LLC, a leading developer of therapies for bladder and bowel dysfunction, announces the issuance of US Patent No. 10,086,034, which relates to pharmacological methods of inducing urination and defecation. Dr. Karl Thor, Chief Scientific Officer and patent co-inventor stated “This is an important…
RESEARCH TRIANGLE PARK, NC and SAN JOSE, CA (September 13, 2023) – Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly and neurologically impaired individuals, today announced that it has entered into a licensing agreement with Aayam Therapeutics (Aayam) to develop compound ATX-003 and related…
RESEARCH TRIANGLE PARK, NC (February 27, 2023) – Dignify Therapeutics LLC, a pharmaceutical and medical device development company focused on restoring bladder and bowel control for people with spinal injury, multiple sclerosis, diabetes, and the elderly, was awarded the prestigious Blueprint Neurotherapeutics Network grant from the National Institutes of Health (NIH). This 4-year award provides…
RESEARCH TRIANGLE PARK, NC (RTP) – June 27, 2022 – Dignify Therapeutics (Dignify), developers of novel treatments for bladder and bowel disorders, is pleased to announce that Anthony DiTonno has joined Dignify Therapeutics as Executive Chairman of the Board of Directors, where he will be integral in guiding Dignify’s future drug development and partnering strategies….
RESEARCH TRIANGLE PARK, NC (September 28, 2020) – Dignify Therapeutics LLC, a drug and medical device development company focused on restoring bladder and bowel control for people with spinal injury, multiple sclerosis, diabetes, and the elderly, has been awarded five new National Institutes of Health (NIH) awards in 2019-2020. These grants provide over $2.5 million…
Dignify Therapeutics and friends (Team Dignify) joined a worldwide walk on September 22nd to support colleagues who are on a journey from Canada to Key West in support of increasing awareness of the impacts of climate change on people with disabilities. Canada to Key West, a 2,500-mile journey to raise awareness about the impact of…
February 5, 2019 FOR IMMEDIATE RELEASE RESEARCH TRIANGLE PARK, NC (February 5, 2019) – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control for people with spinal injury, multiple sclerosis, diabetes, and the elderly, has been awarded CREATE Bio award U44NS106685 by the National Institute of Neurological Disorders and Stroke…
RESEARCH TRIANGLE PARK, NC (RTP) – October 18, 2017 – Dignify Therapeutics, LLC, a leading developer of therapies for bladder and bowel dysfunction, announces the issuance of US Patent No. 10,086,034, which relates to pharmacological methods of inducing urination and defecation. Dr. Karl Thor, Chief Scientific Officer and patent co-inventor stated “This is an important…
Dear Reader, Thank you for joining Dignify Therapeutics’ journey to restore voluntary control of bodily functions to individuals who have spinal cord damage. I assume you are aware of how spinal cord damage from an accident, or from a disease such as multiple sclerosis, can result in the loss of voluntary control over bladder and…